Synthesis and reactivity of 4-, 5- and 6-azaindoles

[41] Potent 4-amino-5-azaindole factor VIIa inhibitors [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (17) : 4567 - 4570

[42] 2-{2-[3-(pyridin-3-yloxy)phenyl]-2H-tetrazol-5-yl}pyridine:: a highly potent, orally active, metabotropic glutamate subtype 5 (mGlu5) receptor antagonist [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (22) : 5473 - 5476

[43] In vivo properties of thiol inhibitors of the three vasopeptidases NEP, ACE and ECE are improved by introduction of a 7-azatryptophan in P2′ position [J]. JOURNAL OF PEPTIDE RESEARCH, 2004, 63 (02): : 99 - 107

[44] Palladium-catalyzed, modular synthesis of highly functionalized indoles and tryptophans by direct annulation of substituted o-haloanilines and aldehydes [J]. JOURNAL OF ORGANIC CHEMISTRY, 2006, 71 (20) : 7826 - 7834

[45] Jiang J. Z., 2005, [No title captured], Patent No. [US/2005/0054631 A 1, 54631, 054631]

[46] Novel non-nucleoside inhibitors of human immunodeficiency virus type 1 reverse transcriptase .6. 2-indol-3-yl- and 2-azaindol-3-yl-dipyridodiazepinones [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (15) : 2430 - 2433

[47] 2-((1H-azol-1-yl)methyl)-N-arylbenzamides:: Novel dual inhibitors of VEGFR-1/2 kinases [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (06) : 1726 - 1730

[48] Synthesis of polyfunctional indoles and related heterocycles mediated by cesium and potassium bases [J]. TETRAHEDRON, 2003, 59 (09) : 1571 - 1587

[49] KUBOTA T, 2004, Patent No. 043363

[50] KUGIMIYA A, 2007, Patent No. 010965

[41] Potent 4-amino-5-azaindole factor VIIa inhibitors [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (17) : 4567 - 4570

[42] 2-{2-[3-(pyridin-3-yloxy)phenyl]-2H-tetrazol-5-yl}pyridine:: a highly potent, orally active, metabotropic glutamate subtype 5 (mGlu5) receptor antagonist [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (22) : 5473 - 5476

[43] In vivo properties of thiol inhibitors of the three vasopeptidases NEP, ACE and ECE are improved by introduction of a 7-azatryptophan in P2′ position [J]. JOURNAL OF PEPTIDE RESEARCH, 2004, 63 (02): : 99 - 107

[44] Palladium-catalyzed, modular synthesis of highly functionalized indoles and tryptophans by direct annulation of substituted o-haloanilines and aldehydes [J]. JOURNAL OF ORGANIC CHEMISTRY, 2006, 71 (20) : 7826 - 7834

[45] Jiang J. Z., 2005, [No title captured], Patent No. [US/2005/0054631 A 1, 54631, 054631]

[46] Novel non-nucleoside inhibitors of human immunodeficiency virus type 1 reverse transcriptase .6. 2-indol-3-yl- and 2-azaindol-3-yl-dipyridodiazepinones [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (15) : 2430 - 2433

[47] 2-((1H-azol-1-yl)methyl)-N-arylbenzamides:: Novel dual inhibitors of VEGFR-1/2 kinases [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (06) : 1726 - 1730

[48] Synthesis of polyfunctional indoles and related heterocycles mediated by cesium and potassium bases [J]. TETRAHEDRON, 2003, 59 (09) : 1571 - 1587

[49] KUBOTA T, 2004, Patent No. 043363

[50] KUGIMIYA A, 2007, Patent No. 010965